These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 38978141

  • 1. Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.
    Liu DSK, Puik JR, Patel BY, Venø MT, Vahabi M, Prado MM, Webber JP, Rees E, Upton FM, Bennett K, Blaker C, Immordino B, Comandatore A, Morelli L, Sivakumar S, Swijnenburg RJ, Besselink MG, Jiao LR, Kazemier G, Giovannetti E, Krell J, Frampton AE.
    J Exp Clin Cancer Res; 2024 Jul 08; 43(1):189. PubMed ID: 38978141
    [Abstract] [Full Text] [Related]

  • 2. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G.
    Clin Transl Med; 2021 Sep 08; 11(9):e520. PubMed ID: 34586739
    [Abstract] [Full Text] [Related]

  • 3. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K, Levink IJM, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ.
    Pancreatology; 2022 Jun 08; 22(5):626-635. PubMed ID: 35613957
    [Abstract] [Full Text] [Related]

  • 4. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu X, Bhandari K, Xu C, Morris K, Ding WQ.
    Int J Mol Sci; 2023 Apr 13; 24(8):. PubMed ID: 37108374
    [Abstract] [Full Text] [Related]

  • 5. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Han Y, Drobisch P, Krüger A, William D, Grützmann K, Böthig L, Polster H, Seifert L, Seifert AM, Distler M, Pecqueux M, Riediger C, Plodeck V, Nebelung H, Weber GF, Pilarsky C, Kahlert U, Hinz U, Roth S, Hackert T, Weitz J, Wong FC, Kahlert C.
    J Hematol Oncol; 2023 Feb 03; 16(1):7. PubMed ID: 36737824
    [Abstract] [Full Text] [Related]

  • 6. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Yu S, Li Y, Liao Z, Wang Z, Wang Z, Li Y, Qian L, Zhao J, Zong H, Kang B, Zou WB, Chen K, He X, Meng Z, Chen Z, Huang S, Wang P.
    Gut; 2020 Mar 03; 69(3):540-550. PubMed ID: 31562239
    [Abstract] [Full Text] [Related]

  • 7. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
    Zeöld A, Sándor GO, Kiss A, Soós AÁ, Tölgyes T, Bursics A, Szűcs Á, Harsányi L, Kittel Á, Gézsi A, Buzás EI, Wiener Z.
    Cell Mol Life Sci; 2021 Mar 03; 78(6):3005-3020. PubMed ID: 33237353
    [Abstract] [Full Text] [Related]

  • 8. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
    Takahashi K, Inuzuka T, Shimizu Y, Sawamoto K, Taniue K, Ono Y, Asai F, Koyama K, Sato H, Kawabata H, Iwamoto H, Yamakita K, Kitano Y, Teramoto T, Fujiya M, Fujii S, Mizukami Y, Okumura T.
    Pancreas; 2024 May 01; 53(5):e395-e404. PubMed ID: 38416857
    [Abstract] [Full Text] [Related]

  • 9. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
    Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S, Korc M.
    Am J Gastroenterol; 2014 Dec 01; 109(12):1942-52. PubMed ID: 25350767
    [Abstract] [Full Text] [Related]

  • 10. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
    Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S.
    Cancer Prev Res (Phila); 2021 Jul 01; 14(7):729-740. PubMed ID: 33893071
    [Abstract] [Full Text] [Related]

  • 11. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals.
    Roy JW, Wajnberg G, Ouellette A, Boucher JE, Lacroix J, Chacko S, Ghosh A, Ouellette RJ, Lewis SM.
    Sci Rep; 2023 Jun 07; 13(1):9251. PubMed ID: 37286718
    [Abstract] [Full Text] [Related]

  • 12. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B, Izetti P, Gregório C, Macedo GS, Castro MA, Osvaldt AB, Matte U, Ashton-Prolla P.
    Pancreas; 2016 Jan 07; 45(1):84-92. PubMed ID: 26262588
    [Abstract] [Full Text] [Related]

  • 13. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
    Kandimalla R, Shimura T, Mallik S, Sonohara F, Tsai S, Evans DB, Kim SC, Baba H, Kodera Y, Von Hoff D, Chen X, Goel A.
    Ann Surg; 2022 Jan 01; 275(1):e229-e237. PubMed ID: 32398486
    [Abstract] [Full Text] [Related]

  • 14. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
    Karasek P, Gablo N, Hlavsa J, Kiss I, Vychytilova-Faltejskova P, Hermanova M, Kala Z, Slaby O, Prochazka V.
    Cancer Genomics Proteomics; 2018 Jan 01; 15(4):321-327. PubMed ID: 29976637
    [Abstract] [Full Text] [Related]

  • 15. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.
    Li X, Xu H, Yi J, Dong C, Zhang H, Wang Z, Miao L, Zhou W.
    J Cell Mol Med; 2021 May 01; 25(10):4671-4683. PubMed ID: 33811437
    [Abstract] [Full Text] [Related]

  • 16. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
    Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, Kim S, Roe DJ, Darabi S, Han IW, Evans DB, Yamada S, Demeure MJ, Becerra C, Celinski SA, Borazanci E, Tsai S, Kodera Y, Park JO, Bolton JS, Wang X, Kim SC, Von Hoff D, Goel A.
    Gastroenterology; 2022 Nov 01; 163(5):1252-1266.e2. PubMed ID: 35850192
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B, Liu X, Gao Y, Li L, Dong Z.
    Br J Biomed Sci; 2016 Oct 01; 73(4):152-157. PubMed ID: 27922430
    [Abstract] [Full Text] [Related]

  • 18. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, Barth RJ, Suriawinata AA, Tsongalis GJ.
    Cancer Genet; 2013 Jun 01; 206(6):217-21. PubMed ID: 23933230
    [Abstract] [Full Text] [Related]

  • 19. Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma.
    Li Q, Geng S, Yuan H, Li Y, Zhang S, Pu L, Ge J, Niu X, Li Y, Jiang H.
    FEBS Open Bio; 2019 Dec 01; 9(12):2052-2062. PubMed ID: 31605569
    [Abstract] [Full Text] [Related]

  • 20. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.
    Clin Transl Gastroenterol; 2019 Apr 01; 10(4):e00029. PubMed ID: 31009404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.